NIH-funded research R01 grant

Vital signs for psychosis: personalized, always-on markers from speech and language

Official title: Vital Signs for Psychosis: Personalized Longitudinal Markers of Psychosis Severity Using Automated Speech and Language Analysis

Funded at Feinstein Institute for Medical Research · NIH-11378668 · Data updated 2026-11-12

A patient-friendly approach to using speech and language cues to measure psychosis severity over time, so clinicians can tailor care.

More Psychosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFeinstein Institute for Medical Research
NIH-funded
Lab location1 site (Manhasset, United States)
Project startAugust 1, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$817,859
NIH project number5R01MH140013-02
Project IDNIH-11378668 on NIH RePORTER

Who could benefit from this research

Could help

Adults with psychosis or related conditions who can participate in regular follow-up assessments over time.

Less likely to help

People who cannot participate in repeated follow-up assessments or have conditions that prevent reliable speech analysis may not benefit.

What this research studies

This project aims to create a low-cost, low-burden way to track psychosis severity using automated analysis of how people speak and what they say. It will adapt advanced models to each person, using repeated measurements over a year to produce personalized “vital signs” of illness. The team will first learn from a large, existing set of speech data from people with psychosis and related conditions, then test four deep-learning strategies in 100 participants over 15–50 timepoints. If successful, this could provide clinicians with actionable, ongoing markers to guide treatment decisions. Participation would involve regular assessments and speaking tasks as part of standard clinical follow-up.

Why it matters

Potential benefit: If successful, patients could receive more timely and personalized care based on objective markers of their psychosis.

How similar studies have gone: Previous work suggests speech and language features can relate to psychosis severity, but this project focuses on personalized, repeated-measures models to enable clinical use.

Where this research is happening

  • Feinstein Institute for Medical Research
    Manhasset, United States
    Active

Researchers

  • Principal investigator: Tang, Sunny Xiaojing — Feinstein Institute for Medical Research
  • Study coordinator: Tang, Sunny Xiaojing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.